These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 29704079)
1. Leptomeningeal disease in uveal melanoma: a case series. Glitza IC; Reddy ST; Patel SP J Neurooncol; 2018 Sep; 139(2):503-505. PubMed ID: 29704079 [No Abstract] [Full Text] [Related]
2. Circulating melanoma cells in peripheral blood of patients with uveal melanoma before and after different therapies and association with prognostic parameters: a pilot study. Suesskind D; Ulmer A; Schiebel U; Fierlbeck G; Spitzer B; Spitzer MS; Bartz-Schmidt KU; Grisanti S Acta Ophthalmol; 2011 Feb; 89(1):17-24. PubMed ID: 21272286 [TBL] [Abstract][Full Text] [Related]
3. [Outcomes and prognosis of uveal melanoblastomas following different variants of combined treatment]. Kotelianskiĭ EO; Zaslavskaia AM Oftalmol Zh; 1983; 38(1):9-12. PubMed ID: 6866409 [No Abstract] [Full Text] [Related]
8. Leptomeningeal melanoma-A case series in the era of modern systemic therapy. Arasaratnam M; Hong A; Shivalingam B; Wheeler H; Guminksi AD; Long GV; Menzies AM Pigment Cell Melanoma Res; 2018 Jan; 31(1):120-124. PubMed ID: 28976629 [No Abstract] [Full Text] [Related]
9. A rare case of leptomeningeal carcinomatosis in a patient with uveal melanoma: case report and review of literature. Fedorenko IV; Evernden B; Kenchappa RS; Sahebjam S; Ryzhova E; Puskas J; McIntosh L; Caceres G; Magliocco A; Etame A; Harbour JW; Smalley KS; Forsyth PA Melanoma Res; 2016 Oct; 26(5):481-6. PubMed ID: 27285292 [TBL] [Abstract][Full Text] [Related]
10. Approach to counseling patients with posterior uveal melanoma. Shields JA; Shields CL; De Potter P Int Ophthalmol Clin; 1993; 33(3):143-5. PubMed ID: 8407179 [No Abstract] [Full Text] [Related]
11. Adjuvant Dendritic Cell Vaccination in High-Risk Uveal Melanoma. Bol KF; van den Bosch T; Schreibelt G; Mensink HW; Keunen JE; Kiliç E; Japing WJ; Geul KW; Westdorp H; Boudewijns S; Croockewit SA; van Rossum MM; de Goede AL; Naus NC; van der Graaf WT; Gerritsen WR; de Klein A; Punt CJ; Figdor CG; Cohen VM; Paridaens D; de Vries IJ Ophthalmology; 2016 Oct; 123(10):2265-7. PubMed ID: 27476772 [No Abstract] [Full Text] [Related]
12. [The pathological basis of the argument in the treatment of melanoma of the uveal tract]. Li YP Zhonghua Yan Ke Za Zhi; 2012 Nov; 48(11):971-5. PubMed ID: 23302268 [TBL] [Abstract][Full Text] [Related]
13. [Risk factors of extraocular spread after local treatment of uveal melanoma]. Neroev VV; Saakian SV; Amirian AG; Val'skiĭ VV Vestn Oftalmol; 2011; 127(2):21-5. PubMed ID: 21721267 [TBL] [Abstract][Full Text] [Related]
14. Uveal melanoma: update and future directions. Rousseau AP Can J Ophthalmol; 2004 Jun; 39(4):335-42. PubMed ID: 15327097 [TBL] [Abstract][Full Text] [Related]
15. How in vitro techniques have increased our understanding of uveal melanoma cellular biology. Marshall JC; Caissie AL; Burnier MN Can J Ophthalmol; 2004 Jun; 39(4):428-32. PubMed ID: 15327109 [TBL] [Abstract][Full Text] [Related]
20. Management and Outcome of Uveal Melanoma in a Single Tertiary Cancer Center in Jordan. Zewar A; Nawaiseh I; Jaradat I; Khzouz J; Alrawashdeh K; Abdeen G; Mehyar M; Khurma S; Yousef YA Turk Patoloji Derg; 2016; 32(3):186-92. PubMed ID: 27562393 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]